secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edesa Biotech, Inc. (EDSA)
CIK:        0001540159
Form:       8-K
Filed at:   2023-03-27T23:59:59+00:00
Accession:  0001104659-23-037164
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edesa Biotech enters ATM equity distribution agreement for up to $20M (current capacity $8.37M)
--------------------------------------------------------------------------------

- Up to $20M aggregate offering price; currently limited to ~$8.37M under S-3 rules.
- Canaccord receives 3% commission; shares sold at-the-market.
- Net proceeds for general corporate purposes including R&D and working capital.
- Agreement dated March 27, 2023; filed as Exhibit 1.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540159/000110465923037164/0001104659-23-037164-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540159/000110465923037164/tm2310425d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-037164

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer